On January 17, 2024, KeyBanc Capital Markets analyst Justin Patterson expressed his positive outlook on Netflix stock, maintaining an Overweight...

As of January 17, 2024, the outlook for Adtran (NASDAQ: ADTN) is a blend of optimism and caution among analysts....

Bristol Myers Squibb (BMS) is set to unveil groundbreaking research at the upcoming American Society of Clinical Oncology 2024 Genitourinary...

On January 17, 2024, three analysts conducted an analysis of DT Midstream (NYSE: DTM), resulting in a range of viewpoints...

On January 17, 2024, Ashwin Shirvaikar, an analyst at Citigroup, expressed his optimistic stance on Endava (NYSE:DAVA). Shirvaikar reiterated a...

On January 17, 2024, Ashwin Shirvaikar, an analyst at Citigroup, expressed his positive outlook on Amdocs (NASDAQ: DOX) by maintaining...

As of January 17, 2024, analysts have differing price targets for Applied Digital Corporation (APLD). John Todaro, an analyst at...

On January 17, 2024, Mitchell Kapoor, an analyst at HC Wainwright & Co., expressed a favorable stance on Neurogene (NASDAQ:NGNE),...

On January 17, 2024, U.S. Bancorp (NYSE: USB) pleasantly surprised investors with its latest quarterly results. The company reported adjusted...

On January 17, 2024, Eric Beaumont, an analyst at Barclays, has reiterated his Equal-Weight rating on Xcel Energy (NASDAQ:XEL) while...